CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Smoking Cessation in Community Settings: Guidelines

Last updated: February 26, 2020
Project Number: RB1445-000
Product Line: Rapid Response
Research Type: Non-Pharma Mental Health Intervention
Report Type: Summary of Abstracts
Result type: Report

Question

  1. What are the evidence-based guidelines regarding the use of nicotine replacement therapy administered by registered nurses in community settings?
  2. What are the evidence-based guidelines regarding the use of varenicline administered by registered nurses in community settings?
  3. What are the evidence-based guidelines regarding the use of bupropion administered by registered nurses in community settings?

Key Message

No evidence-based guidelines were identified regarding the use of nicotine replacement therapy, varenicline, or bupropion administered by registered nurses in community settings.